WPA
ABBV icon

West Paces Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.71M Buy
9,217
+72
+0.8% +$13.4K 0.36% 37
2025
Q1
$1.92M Buy
9,145
+110
+1% +$23K 0.44% 32
2024
Q4
$1.61M Sell
9,035
-513
-5% -$91.2K 0.39% 36
2024
Q3
$1.89M Sell
9,548
-244
-2% -$48.2K 0.46% 31
2024
Q2
$1.68M Sell
9,792
-55
-0.6% -$9.43K 0.44% 36
2024
Q1
$1.79M Sell
9,847
-306
-3% -$55.7K 0.47% 31
2023
Q4
$1.57M Buy
10,153
+399
+4% +$61.8K 0.44% 31
2023
Q3
$1.45M Sell
9,754
-24
-0.2% -$3.58K 0.46% 33
2023
Q2
$1.32M Buy
9,778
+54
+0.6% +$7.28K 0.39% 37
2023
Q1
$1.55M Buy
9,724
+250
+3% +$39.8K 0.48% 32
2022
Q4
$1.53M Sell
9,474
-53
-0.6% -$8.57K 0.49% 31
2022
Q3
$1.28M Sell
9,527
-36
-0.4% -$4.83K 0.45% 31
2022
Q2
$1.46M Buy
9,563
+209
+2% +$32K 0.5% 32
2022
Q1
$1.52M Sell
9,354
-420
-4% -$68.1K 0.47% 31
2021
Q4
$1.32M Buy
9,774
+365
+4% +$49.4K 0.41% 37
2021
Q3
$1.01M Buy
9,409
+7
+0.1% +$755 0.36% 47
2021
Q2
$1.06M Sell
9,402
-341
-3% -$38.4K 0.39% 42
2021
Q1
$1.05M Buy
9,743
+507
+5% +$54.9K 0.42% 41
2020
Q4
$990K Buy
9,236
+946
+11% +$101K 0.44% 40
2020
Q3
$726K Sell
8,290
-41
-0.5% -$3.59K 0.37% 54
2020
Q2
$818K Buy
8,331
+5,015
+151% +$492K 0.44% 43
2020
Q1
$253K Buy
3,316
+1,979
+148% +$151K 0.16% 92
2019
Q4
$118K Buy
1,337
+422
+46% +$37.4K 0.06% 129
2019
Q3
$69.3K Sell
915
-1,943
-68% -$147K 0.04% 157
2019
Q2
$208K Sell
2,858
-588
-17% -$42.8K 0.13% 101
2019
Q1
$278K Sell
3,446
-7,860
-70% -$633K 0.19% 92
2018
Q4
$1.04M Sell
11,306
-193
-2% -$17.8K 0.8% 31
2018
Q3
$1.09M Sell
11,499
-453
-4% -$42.8K 0.78% 25
2018
Q2
$1.11M Buy
11,952
+366
+3% +$33.9K 0.83% 22
2018
Q1
$1.1M Buy
11,586
+441
+4% +$41.7K 0.82% 25
2017
Q4
$1.08M Buy
11,145
+1,004
+10% +$97.1K 0.8% 23
2017
Q3
$901K Buy
10,141
+1,160
+13% +$103K 0.68% 32
2017
Q2
$651K Buy
8,981
+27
+0.3% +$1.96K 0.52% 44
2017
Q1
$583K Buy
8,954
+1,031
+13% +$67.2K 0.47% 54
2016
Q4
$496K Buy
+7,923
New +$496K 0.46% 55